2017 Announcements

Lapse and Forfeit of Unlisted Conditional Performance Rights

12 April 2017

CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY) wishes to advise in accordance with the terms and conditions of issue that the following unquoted conditional performance rights have lapsed and forfeited:

Class Number                    Exercise price             
CUVAK Conditional Performance Rights subject to various performance milestones, issued various dates under the 2009 and 2014 Plans 25,400 $Nil

Consequently, there are now 1,882,260 unlisted conditional performance rights on issue.

Download PDF for more

Go To Top